Zenitar
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Zenitar - overview
Established
2019
Location
Chengdu, Sichuan, China
Primary Industry
Biotechnology
About
Based in Chengdu, China and established in 2019, Chengdu Zenitar Biomedical Technology Co. , Ltd. , trading as Zenitar is a biopharmaceutical research and development company dedicated to the drug research and development. It has acquired High-Tech Enterprise Certificate.
It has 26 independent intellectual property rights and 24 patents. The chairman and CSO of the company, Lijuan Chen graduated from University of Wales Swansea and has worked in Guangdong Zhongsheng Pharmaceutical Co. , Ltd. In January 2026, Zenitar raised CNY 600 million in Series C funding co-led by returning investor Qiming Venture Partners and new investor True Light Capital, with participation from returning investors 5Y Capital, Sichuan Development Industry Led Equity Investment Fund Management, BIO-TOWN Capital, Huajin Lingchuang Fund Management and new investors NRL Capital, Tencent Investment, Lanchi Ventures, Xiamen C&D Group, Shanghai STVC Group.
The company R&D of new drug that includes tumors, autoimmune diseases, and cytokine storm caused by new coronavirus pneumonia. The company's disease research areas include B-cell related tumors, multiple myeloma, polycythemia vera, essential thrombocythemia. The company generates revenue by developing structural biology and artificial intelligence-driven medicines.
Current Investors
New Value Capital, Sichuan Development Industry Led Equity Investment Fund Management, Sichuan Venture Capital
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Oncology/Cancer Treatment
Website
www.zenitar.com.cn/
Verticals
Manufacturing
Company Stage
Series C
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.